02 May 2003
Med Sci Monit 2003; 9(1): 67-0 :: ID: 15206
Poly(ADP ribose) polymerase (PARP) is an abundant nuclear enzyme of eukaryotic cells, which has been implicated in response to DNA injury. Free radical and oxidant induced cell injury can involve the activation of PARP. PARP, when activated by DNA single-strand breaks, initiates an energy consuming cycle by transferring ADP ribose units from NAD to nuclear proteins. The results of this process is a rapid depletion of the intracellular NAD and ATP pools which slows the rate of glycolysis and mitochondrial respiration leading to cellular dysfunction. Recent studies from our group demonstrated the importance of PARP pathway for the pathogenesis of diabetic macrovascular dysfunction, retinopathy and cardiomyopathy. Here we overview our recent progress in the field, which includes (1) delineation of novel molecular mechanisms of the PARP-mediated cellular dysfunction in diabetes, including the link between PARP and pro-inflammatory mediator expression and a link between PARP activation and GAPDH activity suppression; (2) regulation of inflammatory mediator expression by PARP in response to oscillating glucose conditions; (3) recent evidence for PARP activation in tissue specimens of human diabetic patients and (4) recent evidence showing PARP activation in various rodent models of neuropathy, as well as demonstration of the prevention or restoration of the suppression of nerve blood flow and conduction deficit by pharmacological PARP inhibition as well as by genetic PARP deficiency. Overall, PARP emerges as an important novel potential drug target for the correction of various forms of diabetic complications. References: 1.Virág L, Szabó C: The therapeutic potential of PARP inhibition. Pharmacological Reviews, 2002; 54: 375-429 2.Soriano FG, Virág L, Jagtap P et al: Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation. Nature Medicine, 2001; 7: 108-113 3.Pacher P, Liaudet L, Soriano FG et al: The role of poly(ADP-ribose) polymerase in the development of myocardial and endothelial dysfunction in diabetes mellitus. Diabetes, 2002; 51: 514-521
Keywords: vascular dysfunction, endothelium-dependent relaxation, Hyperglycemia, peroxynitrite
01 May 2022 : EditorialEditorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19
Med Sci Monit 2022; 28:e937048
04 May 2022 : Clinical ResearchEffects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936069
27 May 2022 : Clinical ResearchFactors Associated with Falls During Hospitalization for Coronavirus Disease 2019 (COVID-19)
Med Sci Monit 2022; 28:e936547
27 May 2022 : Clinical ResearchPrognostic Significance of Preoperative Integrated Liver Inflammatory Score in Patients with Hepatocellular...
Med Sci Monit In Press; DOI: 10.12659/MSM.937005
25 May 2022 : Review articleNarrative Review of the Mechanism of Hip Prosthesis Dislocation and Methods to Reduce the Risk of Dislocation
Med Sci Monit In Press; DOI: 10.12659/MSM.935665
24 May 2022 : Clinical ResearchRemimazolam Tosilate Sedation with Adjuvant Sufentanil in Chinese Patients with Liver Cirrhosis Undergoing ...
Med Sci Monit In Press; DOI: 10.12659/MSM.936580
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996